Last updated: May 30, 2026
LOREEV XR suppliers: Who manufactures, supplies, and distributes this extended-release drug?
What suppliers make LOREEV XR (loratadine) and who are the likely contract manufacturers?
No complete, reliable supplier-identifying record is available in the provided inputs to name specific manufacturing, API, fill-finish, packaging, or distribution companies for LOREEV XR.
Who supplies the active ingredient for LOREEV XR (API) and what companies control the raw-material chain?
No sourced API-supplier information is available in the provided inputs to identify the loratadine API source(s), intermediate suppliers, or upstream chemical manufacturers tied to LOREEV XR.
Which companies supply LOREEV XR formulations (extended-release technology) such as beads, pellets, or matrix systems?
No sourced formulation/technology supply chain documentation is available in the provided inputs to identify the specific extended-release design used for LOREEV XR or the contract developers/manufacturers responsible for the dosage form.
What packaging and labeling suppliers support LOREEV XR distribution (bottles, blister packs, child-resistant units)?
No sourced packaging or labeling vendor information is available in the provided inputs to identify bottle, blister, desiccant, or child-resistant packaging suppliers used for LOREEV XR.
What is the FDA supply chain footprint for LOREEV XR (FDA facility, NDA/BLA holder, labeler, and manufacturing sites)?
No FDA facility list, labeler name, or manufacturing-site mapping is provided in the inputs to convert LOREEV XR into a facility-by-facility supplier roster.
Is LOREEV XR supplied by the same company that owns the NDA/ANDA, and how does that affect supplier risk?
No NDA/ANDA holder, distributor/labeler, or licensing chain details are provided in the inputs, so the supplier ownership structure cannot be mapped.
Where do LOREEV XR suppliers appear in the Orange Book and labeling (labeler, manufacturer, distributor)?
No Orange Book or prescribing information excerpt is provided in the inputs showing LOREEV XR labeler, applicant, or listed manufacturing/processing facilities.
What wholesale distributors typically handle LOREEV XR in the US and how does that map to manufacturer suppliers?
No wholesaler/distribution channel data is provided in the inputs to identify the specific distributor network for LOREEV XR.
How do LOREEV XR supplier dependencies impact shortages, recalls, and CMO capacity planning?
No plant-level supplier and manufacturing-site information is provided in the inputs to assess dependency, single-site risk, or CMO capacity constraints.
Key Takeaways
- Specific LOREEV XR suppliers (API, CMO, fill-finish, packaging, and distribution) cannot be listed from the provided information.
- No FDA facility, labeler, or Orange Book-linked supplier identifiers are available in the provided inputs to build a verifiable supplier map.
FAQs
- How can I identify the contract manufacturer for LOREEV XR from public records?
- Which FDA database fields reveal the LOREEV XR labeler and manufacturing sites?
- Do LOREEV XR suppliers differ between US commercial supply and clinical-stage supply?
- What documents typically list dosage-form suppliers for extended-release products like LOREEV XR?
- How are LOREEV XR supplier names reflected in package labeling and NDC directory entries?
References
(No sources were provided in the inputs to cite.)
